SCHEMBL5709457

SCHEMBL5709457

CNC(=O)OC1CCN(CCOc2ccc(Cl)cc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.60
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 1/20 0.56
KMT2A Q03164 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
HRH3 Q9Y5N1 9/20 0.54
KCNA5 P22460 3/20 0.52
LTA4H P09960 2/20 0.52
DRD3 P35462 1/20 0.51
DRD2 P14416 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5709509 0.93 SIGMAR1 (0.54) SIGMAR1MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL5709502 0.84 SIGMAR1 (0.60) SIGMAR1MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL28285417 0.82 SIGMAR1 (0.58) SIGMAR1MEN1KMT2AHRH3DRD3
SCHEMBL28619817 0.78 SIGMAR1 (0.62) SIGMAR1MEN1KMT2AHRH3DRD3
SCHEMBL5709483 0.78 LMNA (0.50) ALDH1A1
SCHEMBL5709493 0.78 CARM1 (0.47) HRH3DRD2
SCHEMBL5709497 0.78 DRD3 (0.48) SIGMAR1KMT2ALTA4HDRD3DRD2
SCHEMBL3596798 0.77 HTR1A (0.63) SIGMAR1MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL2980105 0.77 SIGMAR1 (0.54) SIGMAR1MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL28619862 0.76 LTA4H (0.70) SIGMAR1MEN1ALDH1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720550-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS Sanofi-Aventis (FR) 2006-11-15 EP disclosed
WO-2005089759-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2005-09-29 WO disclosed